Replies to post #111761 on Biotech Values

[DewDiligence]

Teva provides 2011 sales and EPS* guidance:

http://finance.yahoo.com/news/Teva-Provides-2011-NonGAAP-bw-347244221.html?x=0&.v=1

It’s clear from Teva’s CC today that no contribution from Lovenox is in Teva’s 2011 guidance. (Nor, for that matter, has any contribution from Lovenox ever been in Teva’s prior guidance—see #msg-58308206.)

Please see #msg-56956538 for Teva’s sales and EPS guidance for 2015, which is unchanged.

*Non-GAAP.